ALLOGENEIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could tailor CMV prevention after stem cell transplants
Disease control Recruiting nowThis phase 2 trial tests whether a blood test that measures CMV-specific immunity (CMV-TCIP) can help doctors decide how long to continue the antiviral drug letermovir after an allogeneic stem cell transplant. Participants receive letermovir for 14 weeks, then the test guides whe…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Lower-Dose drug may make stem cell transplants safer for blood cancer patients
Disease control Recruiting nowThis study tests whether a lower dose of the drug cyclophosphamide can prevent graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. GVHD is a serious complication where donor cells attack the patient's body. The trial will enroll 41 adults and give the…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Tailored transplant doses aim to beat blood cancer
Disease control Recruiting nowThis phase 2 trial tests a personalized approach to stem cell transplants for people with blood cancers like leukemia and lymphoma. Instead of a one-size-fits-all chemotherapy and radiation regimen, doctors adjust the doses based on each patient's risk. The goal is to improve the…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New scan could spot hidden scarring in heart and lungs before It's too late
Diagnosis Recruiting nowThis study tests a new radioactive tracer called 18F-FAPI-74 that may help detect scar tissue (fibrosis) in the heart and lungs earlier than current methods. Researchers will compare this new PET/CT scan to standard imaging in 210 adults with conditions like lung disease or heart…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC